Zhejiang Wecome Pharmaceutical Company Limited Share Price
Equities
300878
CNE1000047P9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.72 CNY | +1.32% | +5.10% | -30.15% |
Sales 2022 | 531M 73.38M 6.12B | Sales 2023 | 520M 71.76M 5.99B | Capitalization | 3.67B 507M 42.33B |
---|---|---|---|---|---|
Net income 2022 | 44M 6.08M 507M | Net income 2023 | -8M -1.1M -92.18M | EV / Sales 2022 | 7.05 x |
Net Debt 2022 | 156M 21.59M 1.8B | Net cash position 2023 | 140M 19.4M 1.62B | EV / Sales 2023 | 6.8 x |
P/E ratio 2022 |
80
x | P/E ratio 2023 |
-423
x | Employees | 1,082 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 24.95% |
1 day | +1.32% | ||
1 week | +5.10% | ||
1 month | -8.38% | ||
3 months | +1.66% | ||
6 months | -29.57% | ||
Current year | -30.15% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Xia Kong
CEO | Chief Executive Officer | 42 | 17/21/17 |
Jing Wang
DFI | Director of Finance/CFO | 37 | 17/21/17 |
Ting Zhu
BRD | Director/Board Member | 35 | 17/21/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bin Wu
BRD | Director/Board Member | 64 | 10/22/10 |
Jiang Feng Liu
BRD | Director/Board Member | 45 | 17/21/17 |
Lan Hao
BRD | Director/Board Member | 56 | 17/21/17 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 17.72 | +1.32% | 2,206,917 |
29/24/29 | 17.49 | +3.74% | 2,126,689 |
26/24/26 | 16.86 | -2.88% | 2,461,080 |
25/24/25 | 17.36 | +1.11% | 1,442,680 |
End-of-day quote Shenzhen S.E., April 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-30.15% | 355M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 300878 Stock